Roche

Hits, but mostly misses for Roche's 4 late-stage trials of GI drug hopeful etrolizumab

4 hours ago   |   Fierce Biotech

Hits, but mostly misses for Roche's 4 late-stage trials of GI drug hopeful etrolizumab badams Mon, 08/10/2020 - 05:29
Read more ...

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

2 days ago   |   Xconomy

The FDA on Friday approved a new spinal muscular atrophy drug that patients can take at home. Risdiplam is a liquid medicine intended for daily use that was developed by Roche...
Read more ...

Biogen to Pay Denali $1B to Partner on Parkinson's Drug & Other Neuro Meds

Biogen to Pay Denali $1B to Partner on Parkinson's Drug & Other Neuro Meds

4 days ago   |   Xconomy   |   2 articles

Denali Therapeutics has selected a brain-penetrating Parkinson's disease drug candidate to advance to late-stage testing and Biogen is paying $1 billion to kick off a...
Read more ...

Dicerna guides Roche-partnered hepatitis B drug past early test

4 days ago   |   Fierce Biotech

Dicerna guides Roche-partnered hepatitis B drug past early test ntaylor Thu, 08/06/2020 - 08:10
Read more ...

MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T

MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T

6 days ago   |   Xconomy

A MorphoSys antibody drug developed for diffuse large B-cell lymphoma has won FDA approval , providing an alternative to cumbersome and risky CAR-T therapies to treat the...
Read more ...

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

9 days ago   |   Xconomy

Kymera Therapeutics has a pipeline of preclinical drug candidates that use an experimental approach to get rid of disease-causing proteins and it's now looking to tap the...
Read more ...

Bio Roundup: Cerevel's Shell, Thrive's Rise, Drug Price Drama & More

Bio Roundup: Cerevel's Shell, Thrive's Rise, Drug Price Drama & More

10 days ago   |   Xconomy

The biotech IPO market is buzzing but Cerevel Therapeutics is showing that there's more than one path to the public markets. This week the neuroscience drug developer reached a...
Read more ...

Roche Pays $120M for Rights to UCB's Tau-Targeting Alzheimer's Drug

Roche Pays $120M for Rights to UCB's Tau-Targeting Alzheimer's Drug

11 days ago   |   Xconomy

As the Alzheimer's disease world continues to closely follow the development of therapies that break up clumps of beta amyloid on patients' brains, Roche is placing a bet on...
Read more ...

Roche drops hep B antiviral as late-stage pipeline tests 'largely on track' despite COVID-19 disruption

18 days ago   |   Fierce Biotech

Roche drops hep B antiviral as late-stage pipeline tests 'largely on track' despite COVID-19 disruption badams Thu, 07/23/2020 - 05:59
Read more ...

Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs

Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs

19 days ago   |   Xconomy   |   3 articles

Elevation Oncology formed last year with $32.5 million in a Series A financing round led by the initial investor in Loxo Oncology, a company that blazed a trail developing...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Scientists Say: Expect More Rainfall Variability for California

Scientists Say: Expect More Rainfall Variability for California

A new study by researchers from the Climate and Ecosystem Sciences Division at Berkeley Lab has shown that a tropical weather pattern will bring a 50% increase in winter... Read more ...

Berkeley Lab Founder Ernest Lawrence to Be Honored With Memorial Highway in...

Berkeley Lab Founder Ernest Lawrence to Be Honored With Memorial Highway in South Dakota

Ernest Lawrence in Canton, South Dakota, in 1913. Lawrence attended Canton High School and received a bachelor's degree in chemistry from the University of South Dakota in 1922... Read more ...

Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3

Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3

An experimental Seres Therapeutics capsule of live bacteria has met the goals of a pivotal study evaluating it as a treatment for a type of recurrent gut infection, preliminary... Read more ...

Imaging method highlights new role for cellular “skeleton” protein

LA JOLLA-While your skeleton helps your body to move, fine skeleton-like filaments within your cells likewise help cellular structures to move. Now, Salk researchers have... Read more ...

Flowering Locus T chimeric protein induces floral precocity in edible citrus

Abstract Citrus is one of the most important fruit crops, with world production exceeding 150 million metric tons in 2018 and a gross production value of 37.5 billion... Read more ...

The miR156/SPL module regulates apple salt stress tolerance by activating...

Summary Salt stress dramatically impedes plant growth and development as well as crop yield. The apple production regions is reduced every year, because of the secondary salt... Read more ...

Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win

Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win badams Mon, 08/10/2020 - 07:08 Read more ...

Hits, but mostly misses for Roche's 4 late-stage trials of GI drug hopeful...

Hits, but mostly misses for Roche's 4 late-stage trials of GI drug hopeful etrolizumab badams Mon, 08/10/2020 - 05:29 Read more ...

Health and Safety of 5G: Addressing Misinformation

As wireless network providers begin to roll out 5G networks, in similar fashion to the introduction of other new technologies-from the microwave oven to smart meters-public... Read more ...

Correction to: Dynamic simulation of continuous mixed sugar fermentation...

An amendment to this paper has been published and can be accessed via the original article. Read more ...